H19 has been reported to be upregulated and promote cell proliferation in breast cancer [44], gastric cancer [45, 46], glioblastoma [47] and lung cancer [26], while it is downregulated and decreases proliferation in papillary thyroid carcinoma [48] and hepatocellular carcinoma [49]. This evidence concerns the gene H19 and differentiated thyroid carcinoma.